Citigroup Inc Asensus Surgical, Inc. Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$0.36 - $1.0 $1,096 - $3,047	3,047 New	3,047 $2,000
Q2 2022 Aug 10, 2022	SELL	$0.37 - $0.61 $20,992 - $34,608	-56,736 Reduced 95.9%	2,426 $1,000
Q1 2022 May 12, 2022	SELL	$0.53 - $1.19 $66,049 - $148,298	-124,621 Reduced 67.81%	59,162 $37,000
Q4 2021 Feb 10, 2022	BUY	$1.03 - $2.31 $58,371 - $130,910	56,671 Added 44.58%	183,783 $204,000
Q3 2021 Nov 10, 2021	BUY	$1.74 - $2.93 $221,174 - $372,438	127,112 New	127,112 $235,000

40.1M

12.4K

Ticker ASXC
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 236,719,008
Market Cap $82.9M
Description
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical int...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.